PF
PPH icon

Phoenix Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History

Phoenix Financial’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-59,583
Closed -$4.63M – 354
2023
Q1 		$4.63M Buy
+59,583
New +$4.59M 0.1% 94

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Phoenix Financial's PPH Position: Q1 2026 in Review

Phoenix Financial reduced its VanEck Pharmaceutical ETF (PPH) stake by 68% in Q1 2026, selling an estimated $3.62M and leaving 16,052 shares worth $1.67M. The position accounts for 0.02% of the portfolio, ranked #191.

Phoenix Financial first reported a position in PPH in Q1 2022 and has held it in 17 quarters since. The position peaked at $171M in Q4 2022. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Phoenix Financial held 16,052 shares of VanEck Pharmaceutical ETF worth $1.67M as of Q1 2026.
  • Phoenix Financial sold 34,024 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $3.62M.
  • VanEck Pharmaceutical ETF made up 0.02% of Phoenix Financial's portfolio in Q1 2026, its #191 holding.
  • Phoenix Financial first reported a position in VanEck Pharmaceutical ETF in Q1 2022 and has held it in 17 quarters since.
  • Phoenix Financial's VanEck Pharmaceutical ETF position peaked at $171M in Q4 2022.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.